NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer

WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (PCORI) has appointed its first chief science officer, marking an important progress step in its research activities. PCORI has named Dr. Bryan Luce to fill this new role.

“A chief science officer will have an integral role in leading and overseeing the research that PCORI will be funding,” said NPC President Dan Leonard. “With the increase in PCORI’s research activities, this appointment comes at an important time.

“Dr. Luce is respected not only for his knowledge and experience of research methods, but also for his ability to collaborate with a wide variety of health care stakeholders,” Leonard added.

Dr. Luce has collaborated with stakeholders through a number of working groups and organizations, such as the Medicare Evidence Development and Coverage Advisory Committee (MedCAC) and the Pragmatic Approaches to Comparative Effectiveness (PACE) Initiative, among others. NPC staff also had the opportunity to work with Dr. Luce on several projects, including Principles for Planning and Conducting Comparative Effectiveness Research (2012) and The Current Evidence-Based Medicine Landscape (2008).

“He has dedicated his career to improving research methods and related policies for more effective health care decision-making,” said Robert Dubois, MD, PhD, NPC chief science officer. “We look forward to working with Dr. Luce in his new role and stand ready to support him as he takes on this next challenge in his career.”


About the National Pharmaceutical Council

The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation’s major research-based pharmaceutical companies, NPC focuses on research, development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit and follow NPC on Twitter @npcnow.